Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-04-28 4:17 pm Sale |
2023-04-27 | 13G | Provention Bio, Inc. PRVB |
Sessa Capital (Master), L.P. | 0 0.000% |
-18,403,628 (Position Closed) |
Filing History |
| 2023-04-05 08:51 am Purchase |
2023-03-31 | 13G | Provention Bio, Inc. PRVB |
Sessa Capital (Master), L.P. | 18,403,628 17.800% |
337,015 (+1.87%) |
Filing History |
| 2023-02-21 4:50 pm Purchase |
2023-02-09 | 13G | Provention Bio, Inc. PRVB |
ADAGE CAPITAL PARTNERS GP LLC | 5,398,825 6.010% |
2,879,568 (+114.30%) |
Filing History |
| 2023-02-14 4:08 pm Sale |
2022-12-31 | 13G | Provention Bio, Inc. PRVB |
Venrock Healthcare Capital Partners II, L.P. | 1,118,653 1.300% |
-2,725,143 (-70.90%) |
Filing History |
| 2023-02-14 3:00 pm Purchase |
2022-12-31 | 13G | Provention Bio, Inc. PRVB |
Sessa Capital (Master), L.P. | 18,066,613 19.990% |
2,456,443 (+15.74%) |
Filing History |
| 2023-02-09 11:07 am Sale |
2022-12-31 | 13G | Provention Bio, Inc. PRVB |
ADAGE CAPITAL PARTNERS GP LLC | 2,519,257 2.890% |
-2,780,743 (-52.47%) |
Filing History |
| 2023-01-31 5:52 pm Purchase |
2022-12-31 | 13G | Provention Bio, Inc. PRVB |
BLACKROCK INC BLK |
5,579,604 6.400% |
1,095,679 (+24.44%) |
Filing History |
| 2022-08-26 4:30 pm Purchase |
2022-08-16 | 13G | Provention Bio, Inc. PRVB |
ADAGE CAPITAL PARTNERS GP LLC | 5,300,000 6.500% |
5,300,000 (New Position) |
Filing History |
| 2022-07-11 5:29 pm Purchase |
2022-07-07 | 13G | Provention Bio, Inc. PRVB |
Sessa Capital (Master), L.P. | 15,610,170 19.990% |
9,714,645 (+164.78%) |
Filing History |
| 2022-02-14 5:29 pm Purchase |
2021-12-31 | 13G | Provention Bio, Inc. PRVB |
Sessa Capital (Master), L.P. | 5,895,525 9.300% |
5,895,525 (New Position) |
Filing History |
| 2022-02-14 5:18 pm Sale |
2021-12-31 | 13G | Provention Bio, Inc. PRVB |
PERCEPTIVE ADVISORS LLC | 948,481 1.500% |
-2,684,542 (-73.89%) |
Filing History |
| 2022-02-03 4:29 pm Purchase |
2021-12-31 | 13G | Provention Bio, Inc. PRVB |
BLACKROCK INC BLK |
4,483,925 7.100% |
558,436 (+14.23%) |
Filing History |
| 2021-06-07 4:30 pm Purchase |
2021-05-26 | 13G | Provention Bio, Inc. PRVB |
Venrock Healthcare Capital Partners II, L.P. | 3,843,796 6.100% |
3,843,796 (New Position) |
Filing History |
| 2021-04-19 4:30 pm Sale |
2021-04-09 | 13G | Provention Bio, Inc. PRVB |
PERCEPTIVE ADVISORS LLC | 3,633,023 5.700% |
-591,366 (-14.00%) |
Filing History |
| 2021-02-16 5:02 pm Purchase |
2020-12-31 | 13G | Provention Bio, Inc. PRVB |
APPEL PETER A | 2,262,500 4.010% |
312,500 (+16.03%) |
Filing History |
| 2021-02-16 3:33 pm Purchase |
2020-12-31 | 13G | Provention Bio, Inc. PRVB |
PERCEPTIVE ADVISORS LLC | 4,224,389 6.700% |
1,302,815 (+44.59%) |
Filing History |
| 2021-02-05 4:31 pm Unchanged |
2020-12-31 | 13G | Provention Bio, Inc. PRVB |
AMGEN INC AMGN |
2,500,000 4.426% |
0 (Unchanged) |
Filing History |
| 2021-02-02 3:13 pm Purchase |
2020-12-31 | 13G | Provention Bio, Inc. PRVB |
BLACKROCK INC BLK |
3,925,489 6.900% |
3,925,489 (New Position) |
Filing History |